Clinical trials
Phase 1 Dyslipidemias trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 6 |
| 2016 | 2 |
| 2019 | 4 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 34 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 15 |
| Eli Lilly and Company | 5 |
| Pfizer | 4 |
| Kowa Research Institute, Inc. | 2 |
| Novartis Pharmaceuticals | 2 |
| University of Pennsylvania | 2 |
| CRISPR Therapeutics AG | 1 |
| Catabasis Pharmaceuticals | 1 |
| Children's Mercy Hospital Kansas City | 1 |
| Columbia University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 41 |
| Hypercholesterolemia | 11 |
| Hyperlipidemias | 5 |
| Diabetes Mellitus, Type 2 | 3 |
| Hypertriglyceridemia | 3 |
| Lipid Metabolism Disorders | 3 |
| Metabolic Diseases | 3 |
| Non-alcoholic Fatty Liver Disease | 3 |
| Diabetes Mellitus | 2 |
| Obesity | 2 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.